Pharma Tech

[Pharma Tech @Pharma_Tech]

Ranbaxy to introduce malarial treatment Synriam in African nations http://t.co/t1rMUTD8lN

[Pharma Tech @Pharma_Tech]

Novartis receives FDA approval for Signifor LAR to treat acromegaly http://t.co/sD6bZV6xFD

[Pharma Tech @Pharma_Tech]

Boehringer starts patient enrolment in dabigatran Phase III trial to prevent ESUS: Boehringer Ingelheim has st... http://t.co/4W8ljisYlu

[Pharma Tech @Pharma_Tech]

Acorda begins patient enrolment in Phase III trial of dalfampridine to treat PSWD: US-based biotechnology firm... http://t.co/4whq2TeIOj

[Pharma Tech @Pharma_Tech]

Novartis' Phase IIIb CLEAR trial of psoriasis drug Cosentyx meets endpoints: Swiss drug-maker Novartis has rep... http://t.co/q1o6zozyDm

[Pharma Tech @Pharma_Tech]

Nanotherapeutics to acquire Baxter’s Vero cell vaccines platform http://t.co/9ez2U8WcYv

[Pharma Tech @Pharma_Tech]

Pfizer and OPKO collaborate to develop and commercialise hGH-CTP to treat GHD http://t.co/Gl26M2bMm2

[Pharma Tech @Pharma_Tech]

Fujifilm Diosynth Biotechnologies' UK Site Received Renewed MHRA Manufacturing Licence http://t.co/r75StABsGA

[Pharma Tech @Pharma_Tech]

Boehringer reports positive results from LUX-Breast 1 and LUX-Breast 3 trials: Boehringer Ingelheim has report... http://t.co/DcXO51z7AD

[Pharma Tech @Pharma_Tech]

Karyopharm begins Phase IIb trial of lymphoma drug selinexor: Karyopharm Therapeutics has started a registrati... http://t.co/2eg5QMO5fo

[Pharma Tech @Pharma_Tech]

Better together? Combining therapies to slow down cancer growth http://t.co/1WBejU76lk

[Pharma Tech @Pharma_Tech]

Arno begins dosing in modified Phase I/II trial evaluating cancer drug onapristone: US-based biopharmaceutical... http://t.co/xJEntXnz1N

[Pharma Tech @Pharma_Tech]

Alnylam begins Phase III ENDEAVOUR trial of revusiran in FAC patients: US-based Alnylam Pharmaceuticals has st... http://t.co/zIGRNQ9zOn

[Pharma Tech @Pharma_Tech]

New Zealand approves Mylan-Abbott $5bn deal http://t.co/toKYVjaDZV

[Pharma Tech @Pharma_Tech]

UK reserves ready for Sierra Leone deployment to fight against Ebola http://t.co/Xe6GG3J0fI

[Pharma Tech @Pharma_Tech]

Vetter Development Service Chicago Is Ready for Realising Clinical Syringe Projects http://t.co/sRhS8PePu7

[Pharma Tech @Pharma_Tech]

Pharma Technology Focus - Issue 32 http://t.co/k4VqDll5JT

[Pharma Tech @Pharma_Tech]

BMS, Ono and Kyowa Hakko to conduct Phase I combination trial to treat cancers: Bristol-Myers Squibb (BMS), On... http://t.co/4DZlnc9lQU

[Pharma Tech @Pharma_Tech]

ContraVir begins pharmacokinetic trial of FV-100 to treat shingles: US-based ContraVir Pharmaceuticals has sta... http://t.co/6Yzi32hhdu

[Pharma Tech @Pharma_Tech]

Germany bans 80 generic drugs trialled at GVK Biosciences facility in India http://t.co/R7GUNVibDw